PET-MF

Clinical trials for PET-MF explained in plain language.

Never miss a new study

Get alerted when new PET-MF trials appear

Sign up with your email to follow new studies for PET-MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for blood cancer patients who failed standard treatment

Disease control Recruiting now

This early-stage trial is testing a new oral medication called AJ1-11095 for adults with myelofibrosis, a serious bone marrow cancer. The study is for patients whose disease didn't respond well to or came back after standard JAK2 inhibitor treatment. Researchers will determine th…

Matched conditions: PET-MF

Phase: PHASE1 • Sponsor: Ajax Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PET-MF

Get alerted when new PET-MF trials appear

New hope for blood cancer patients who failed standard treatment